Tolterodine Tartrate NDC 31722-805

NDC codes

FDA NDC Directory

Product NDC (as listed)31722-805Labeler and product segments. Claims need a package NDC.

Product NDC at billing width31722-0805Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
31722-805-01	31722080501	10 BLISTER PACK in 1 CARTON (31722-805-01) / 10 TABLET, FILM COATED in 1 BLISTER PACK (31722-805-31)Marketed from Aug 2, 2021
31722-805-02	31722080502	10 BLISTER PACK in 1 CARTON (31722-805-02) / 10 TABLET, FILM COATED in 1 BLISTER PACK (31722-805-32)Marketed from Aug 2, 2021
31722-805-05	31722080505	500 TABLET, FILM COATED in 1 BOTTLE (31722-805-05)Marketed from Aug 2, 2021
31722-805-60	31722080560	60 TABLET, FILM COATED in 1 BOTTLE (31722-805-60)Marketed from Aug 2, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Tolterodine Tartrate
Generic name (nonproprietary): tolterodine tartrate
Active ingredients: Tolterodine tartrate — 1 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Camber Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 204397
Marketing start: Aug 2, 2021
Listing expires: Dec 31, 2026
Other FDA classes: Cholinergic Muscarinic Antagonists (Mechanism)
Identifiers: Product ID 31722-805_c9a8a649-3330-59a0-e053-2995a90ad3c3SPL ID c9a8a649-3330-59a0-e053-2995a90ad3c3SPL set ID f67fce7c-69d3-42ae-8c1d-2e26fd4d7415RxCUI 855178, 855194UNII 5T619TQR3RUPC 0331722806602, 0331722805605
Pharmacologic class: Cholinergic Muscarinic Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N431722080501 followed by a unit qualifier and the quantity

Package 31722-0805-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 16, 2021.

Indications (excerpt from the label)

INDICATIONS AND USAGE Tolterodine tartrate tablets are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 204397

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 204397
Product	Strength	Form · route	Labeler	Product NDC
Tolterodine Tartrate	Tolterodine tartrate 2 mg/1	Tablet, Film coatedOral	Camber Pharmaceuticals, Inc.	31722-806